Page last updated: 2024-11-02

oxidopamine and Cell Transformation, Neoplastic

oxidopamine has been researched along with Cell Transformation, Neoplastic in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thinyane, K1
Baier, PC1
Schindehütte, J1
Mansouri, A1
Paulus, W1
Trenkwalder, C1
Flügge, G1
Fuchs, E1
Mirkin, BL1
Fink, DW1
O'Dea, RF1

Other Studies

2 other studies available for oxidopamine and Cell Transformation, Neoplastic

ArticleYear
Fate of pre-differentiated mouse embryonic stem cells transplanted in unilaterally 6-hydroxydopamine lesioned rats: histological characterization of the grafted cells.
    Brain research, 2005, May-31, Volume: 1045, Issue:1-2

    Topics: Animals; Biomarkers; Brain Neoplasms; Cell Count; Cell Differentiation; Cell Lineage; Cell Prolifera

2005
"In situ" modulation of murine neuroblastoma growth and biochemical differentiation by the adrenergic nervous system and nerve growth factor.
    Progress in clinical and biological research, 1988, Volume: 271

    Topics: Adrenergic Fibers; Aging; Animals; Catecholamines; Cell Transformation, Neoplastic; Hydroxydopamines

1988